# clm_1A5FC1FEF0D4

subject: Amgen (/record/amgen.md)  
predicate: quarterly_net_income  
value: 2,841,000,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-04-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2B91AA0524E8  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly net income: 2,841,000,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_1A5FC1FEF0D4, https://asof.is/claim/clm_1A5FC1FEF0D4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815423000029/0000318154-23-000029-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-04-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815423000029/0000318154-23-000029-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-04-28)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_net_income | 2,143,000,000 United States dollar | valid 2022-09-30 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_1A5FC1FEF0D4](/claim/clm_1A5FC1FEF0D4.md) | [clm_35CDE21699AB](/claim/clm_35CDE21699AB.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.